CIRCULATING CANCER-ASSOCIATED-MACROPHAGE-LIKE CELLS (CAMLs) AND CIRCULATING TUMOR CELLS EVALUATED IN A DOUBLE-BLIND STUDY AS DIAGNOSTIC BIOMARKERS IN THE BLOOD FOR PATIENTS WITH INDETERMINATE LUNG NODULES
MONMOUTH JUNCTION, N.J., Nov. 17, 2026 /PRNewswire/ -- Creatv Bio, a Division of Creatv MicroTech, Inc. ("Creatv"), a liquid biopsy company focused on innovative diagnostics for cancer, participated in a double-blind study with the Fox Chase Cancer Center and the University of...